Sterling Investment Advisors (Pennsylvania)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-120
Closed -$7K 364
2022
Q2
$7K Hold
120
﹤0.01% 431
2022
Q1
$7K Hold
120
﹤0.01% 471
2021
Q4
$7K Buy
120
+20
+20% +$1.08K ﹤0.01% 468
2021
Q3
$5K Hold
100
﹤0.01% 482
2021
Q2
$4K Hold
100
﹤0.01% 473
2021
Q1
$3K Buy
+100
New +$3.56K ﹤0.01% 476

Other funds holding NVO

Sterling Investment Advisors (Pennsylvania)'s NVO Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 120 shares — an estimated $7K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in NVO in Q1 2021 and held it in 6 quarters. The position peaked at $7K in Q2 2022. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 120 Novo Nordisk shares in Q3 2022, an estimated $7K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Novo Nordisk in Q1 2021 and held it in 6 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Novo Nordisk position peaked at $7K in Q2 2022.
  • 908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.